JP2009522376A5 - - Google Patents

Download PDF

Info

Publication number
JP2009522376A5
JP2009522376A5 JP2008549657A JP2008549657A JP2009522376A5 JP 2009522376 A5 JP2009522376 A5 JP 2009522376A5 JP 2008549657 A JP2008549657 A JP 2008549657A JP 2008549657 A JP2008549657 A JP 2008549657A JP 2009522376 A5 JP2009522376 A5 JP 2009522376A5
Authority
JP
Japan
Prior art keywords
composition
mammal
administering
pharmaceutically acceptable
acceptable carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008549657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009522376A (ja
Filing date
Publication date
Priority claimed from US11/327,586 external-priority patent/US7611739B2/en
Application filed filed Critical
Publication of JP2009522376A publication Critical patent/JP2009522376A/ja
Publication of JP2009522376A5 publication Critical patent/JP2009522376A5/ja
Pending legal-status Critical Current

Links

JP2008549657A 2006-01-06 2007-01-05 グアバ抽出物を使用する方法及びグアバ抽出物を含む組成物 Pending JP2009522376A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/327,586 US7611739B2 (en) 2006-01-06 2006-01-06 Method of using guava extract and composition including guava extract
PCT/US2007/060157 WO2007112138A2 (en) 2006-01-06 2007-01-05 Method of using guava extract and composition including guava extract

Publications (2)

Publication Number Publication Date
JP2009522376A JP2009522376A (ja) 2009-06-11
JP2009522376A5 true JP2009522376A5 (enExample) 2010-01-28

Family

ID=38232997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008549657A Pending JP2009522376A (ja) 2006-01-06 2007-01-05 グアバ抽出物を使用する方法及びグアバ抽出物を含む組成物

Country Status (13)

Country Link
US (3) US7611739B2 (enExample)
EP (1) EP1976544B1 (enExample)
JP (1) JP2009522376A (enExample)
CN (1) CN101360507B (enExample)
AT (1) ATE467420T1 (enExample)
AU (1) AU2007230860B2 (enExample)
CA (1) CA2635281A1 (enExample)
DE (1) DE602007006419D1 (enExample)
ES (1) ES2345067T3 (enExample)
PL (1) PL1976544T3 (enExample)
PT (1) PT1976544E (enExample)
RU (1) RU2405564C2 (enExample)
WO (1) WO2007112138A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US20090068300A1 (en) * 2007-09-07 2009-03-12 Veripak, Inc. Pre- and post-workout formulations processes and supplement products thereby
WO2010005438A1 (en) * 2008-07-10 2010-01-14 Amerilab Technologies, Inc. Method of treating migraine using guava
US20100215758A1 (en) * 2009-02-25 2010-08-26 Joar Opheim Effervescent nutritional and/or dietary supplement composition
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
WO2011133911A1 (en) * 2010-04-22 2011-10-27 Amerilab Technologies, Inc. An effervescent carrier, a method of changing the flavor of milk, and an effervescent tablet for changing the flavor of milk
US20110318468A1 (en) * 2010-06-29 2011-12-29 Aleksandre Kakhaberi Fructose-based anti-diabetic alcoholic beverage and method of making same
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics
WO2013173918A1 (en) 2012-05-24 2013-11-28 Husky Injection Molding Systems Ltd. A method of transferring a molded article
FI129157B (en) * 2012-05-28 2021-08-13 Biohit Oyj Composition for use in reducing the incidence of or preventing severe headaches
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
US11648201B2 (en) * 2018-05-02 2023-05-16 Ferring B.V. Pharmaceutical formulations
CN113841814A (zh) * 2021-05-13 2021-12-28 佳纬生物技术有限公司 一种适用于巴沙鱼和日本沼虾混养饲料及其无公害混养方法
EP4115741B1 (en) * 2021-11-16 2024-09-25 Pompadour Ibérica S.A. A beverage composition with controlled effervescence for infusion in a cold liquid

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6036746B2 (ja) * 1983-09-06 1985-08-22 備前化成株式会社 グアバ葉エキスからなる健康飲料
JPS6137731A (ja) * 1984-07-31 1986-02-22 Bizen Kasei Kk グアバ葉エキスを有効成分とする経口糖尿病薬
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
RU2097053C1 (ru) * 1994-09-26 1997-11-27 Анна Геннадьевна Пономарева Лекарственный сбор "петрович" для снятия тяги к алкоголю
JP3222021B2 (ja) 1994-09-29 2001-10-22 長谷川香料株式会社 虫歯防止剤
JPH092969A (ja) * 1995-06-20 1997-01-07 O S Kogyo Kk アレルギー疾患治療剤
JP3625900B2 (ja) 1995-06-29 2005-03-02 株式会社ヤクルト本社 腎臓疾患治療剤
JP3871370B2 (ja) * 1996-02-28 2007-01-24 株式会社ロッテ 精神安定用剤
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
US5955057A (en) * 1998-06-12 1999-09-21 Biotech Holdings Ltd. Effervescing or foaming bath shape or solid
US6171633B1 (en) * 1998-08-14 2001-01-09 Natura, Inc. Milk-based drink
JP2001039884A (ja) * 1999-08-02 2001-02-13 T Hasegawa Co Ltd 歯周病防止剤
GB9920270D0 (en) * 1999-08-26 1999-10-27 Bush Boake Allen Ltd Flavouring agent and methods for preparing and using same
US20020172738A1 (en) * 1999-09-13 2002-11-21 Young Thomas B. Alcohol sweetened and sparkling fruit ciders and method for same
JP2001226274A (ja) 2000-02-09 2001-08-21 Matsuura Yakugyo Kk リパーゼ阻害剤
TWI261497B (en) 2000-03-10 2006-09-11 Yakult Honsha Kk alpha-amylase activity inhibitor
JP2002255837A (ja) 2001-03-01 2002-09-11 Mikimoto Pharmaceut Co Ltd アルドースレダクターゼ阻害剤
ES2173047B1 (es) 2001-03-21 2004-01-01 Aplicaciones Farmacodinamicas Procedimiento para la obtencion de las diferentes fracciones de guayaba atomizada y su uso para el tratamiento de la diabetes mellitus tipo ii
RU2181593C1 (ru) * 2001-04-18 2002-04-27 Миронов Владимир Андреевич Микстура для дезинтоксикации организма и способ лечения алкоголизма и наркомании с использованием микстуры
KR100443264B1 (ko) 2001-06-07 2004-08-04 한국생명공학연구원 구아바로부터 얻은 단백질 타이로신 탈인산화 효소 １ｂ 저해용 활성분획 추출물
US6824798B2 (en) 2001-09-27 2004-11-30 J. Gregory Koenig Method of preventing veisalgia
JP2003189828A (ja) 2001-12-28 2003-07-08 Yamaguchi Chagyo:Kk 茶代用品
US6616950B2 (en) * 2002-01-14 2003-09-09 Council Of Scientific And Industrial Research Fermented herbal health drink from plant andrographis
US6811793B2 (en) * 2002-03-11 2004-11-02 Amerilab Technologies, Inc. Effervescent composition including stevia
JP2004075571A (ja) 2002-08-12 2004-03-11 Os Kogyo Kk 点鼻剤およびその製造方法
FI20021819A0 (fi) * 2002-10-14 2002-10-14 Pekka Untamo Heino Valmiste alkoholin metabolian tehostamiseksi
KR20030026939A (ko) 2003-01-27 2003-04-03 최미회 구아바잎을 주성분으로한 당뇨병치료용, 비만개선용,노화방지용차의 효과적인 조성물 및 이를 함유한 건강식품
JP2004267075A (ja) 2003-03-07 2004-09-30 Washi Kosan Co Ltd 過剰栄養分のエネルギー代謝を阻害する主食用米飯
CN100496561C (zh) * 2003-05-22 2009-06-10 北京大学 一种改善糖耐量和治疗糖尿病及肥胖症的药物及其制备方法
CN1245193C (zh) * 2003-05-23 2006-03-15 李森青 含有硫化丙烯辛香气味植物的发酵素、其制备方法及其用途
KR20040066768A (ko) 2004-07-07 2004-07-27 홍진경 구아바와 야콘을 이용한 당뇨치료용 조성물 및 그 제조방법

Similar Documents

Publication Publication Date Title
JP2009522376A5 (enExample)
JP2010535814A5 (enExample)
JP2008044951A5 (enExample)
WO2007095600A3 (en) Disintegrable oral films
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
WO2008011596A3 (en) Hydrophilic abuse deterrent delivery system
WO2014093127A3 (en) Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit
JP2005512995A5 (enExample)
WO2010062688A3 (en) Dosage form for insertion into the mouth
MX2009000507A (es) Espuma farmaceutica de acidos grasos.
WO2009017838A3 (en) Combinations of jak-2 inhibitors and other agents
IL192104A (en) Formulation suitable for subcutaneous administration containing molecules of ctla4ig, sugar and liquid liquid pharmacist acceptable and its use in drug preparation
WO2006044421A3 (en) Cardiac safe, rapid medication delivery
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
MX2010010954A (es) Farmaco contra cancer de higado.
JP2010518086A5 (enExample)
ECSP10010052A (es) Formulaciones galenicas de alisquireno y valsartan
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
HRP20150949T1 (hr) UPORABA 24-norUDCA
MX2009003771A (es) Formulaciones robustas de liberacion sostenida.
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
CN103340833B (zh) 一种芬太尼双层口颊片及其制备方法
WO2008051527A3 (en) Sustained release of agents for localized pain management
HRP20100373T4 (hr) Upotreba kombinacije morfina s najmanje jednim opijatnim antagonistom u liječenju ovisnosti o opijatima i u sprječavanju neoralne zloupotrebe opijata kod ovisnika opijatima
WO2007145863A3 (en) Sustained release formulation of naltrexone